Cullinan Therapeutics Inc (CGEM)
15.30
-0.49
(-3.10%)
USD |
NASDAQ |
Nov 14, 16:00
15.31
+0.01
(+0.07%)
After-Hours: 16:58
Cullinan Therapeutics Shareholders Equity (Quarterly): 656.22M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 656.22M |
| March 31, 2024 | 425.66M |
| December 31, 2023 | 453.70M |
| September 30, 2023 | 468.82M |
| June 30, 2023 | 499.57M |
| March 31, 2023 | 485.65M |
| December 31, 2022 | 535.03M |
| September 30, 2022 | 586.13M |
| June 30, 2022 | 604.54M |
| Date | Value |
|---|---|
| March 31, 2022 | 418.70M |
| December 31, 2021 | 424.97M |
| September 30, 2021 | 443.39M |
| June 30, 2021 | 455.55M |
| March 31, 2021 | 466.90M |
| December 31, 2020 | 199.01M |
| September 30, 2020 | 212.35M |
| December 31, 2019 | -40.77M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-40.77M
Minimum
Dec 2019
656.22M
Maximum
Jun 2024
429.14M
Average
455.55M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| CEL-SCI Corp | 8.473M |
| AIM ImmunoTech Inc | 6.102M |
| IGC Pharma Inc | 7.88M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Protalix BioTherapeutics Inc | 28.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 681.22M |
| Total Liabilities (Quarterly) | 25.00M |